Metildigoxin

DB13401InvestigationalSmall molecule

Metildigoxin is a digitalis glycoside indicated in the treatment of acute and chronic heart failure. A medication used to treat heart failure.

Chemical structure of Metildigoxin
Mechanism
Curator reviewed
Formula / weight
C42H66O14 · 794.976 g/mol (avg)

Resolves to

Clinical / RWD
Structure
InChIKeyIYJMSDVSVHDVGT-PEQKVOOWSA-NSMILES[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@]([H])(CC[C@]4(C)[C@@]3([H])C[C@@]([H])(O)[C@]12C)O[C@@]1([H])C[C@]([H])(O)[C@]([H])(O[C@@]2([H])C[C@]([H])(O)[C@]([H])(O[C@@]3([H])C[C@]([H])(O)[C@]([H])(OC)[C@@]([H])(C)O3)[C@@]([H])(C)O2)[C@@]([H])(C)O1)C1=CC(=O)OC1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
807Drug interactionsStructured to mechanism, not free text
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
5ContraindicationsEach with its own population and attribute set
Sign in
20Marketed productsAcross 4 countries and 7 labellers
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Metildigoxin, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account